|Study Description:||The goal of this clinical research study is to learn if BKM120 can help to |
control the disease in patients with relapsed/refractory DLBCL, MCL, or FL.
The safety of this drug will also be studied.
BKM120 is designed to block a protein that is important to the growth and
division of cancer cells, which may cause the cells to die.